Abbott receives FDA approval for AI coronary imaging device

Medical device company Abbott recently gained FDA approval for its new AI-powered software, Radiology Business reported Aug. 3.

Advertisement

The company’s Ultreon Software combines imaging techniques with artificial intelligence algorithms to give cardiologists a complete view of patients’ coronary blood vessels for enhanced assistance with various treatment options.

Abbott received clearance to market the device in Europe in April.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Cardiology

Advertisement

Comments are closed.